Cargando…

Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B

SIMPLE SUMMARY: Predicting hepatocellular carcinoma in patients with chronic hepatitis B who receive long-term treatment with entecavir or tenofovir is of particular importance in terms of the allocation of medical resources for cancer surveillance. The Cirrhosis and Age (CAGE-B) and Stiffness and A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Jihye, Chon, Young Eun, Kim, Mi Na, Lee, Joo Ho, Hwang, Seong Gyu, Lee, Han Chu, Ha, Yeonjung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615754/ https://www.ncbi.nlm.nih.gov/pubmed/34830764 http://dx.doi.org/10.3390/cancers13225609

Ejemplares similares

Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
por: Ha, Yeonjung, et al.
Publicado: (2020)

Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study
por: Ha, Yeonjung, et al.
Publicado: (2019)

Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
por: Cho, Heejin, et al.
Publicado: (2023)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019)

Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function
por: Ha, Yeonjung, et al.
Publicado: (2018)

Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease
por: Chon, Young Eun, et al.
Publicado: (2020)

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
por: Kim, Mi Na, et al.
Publicado: (2021)

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
por: Chon, Young Eun, et al.
Publicado: (2022)

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
por: Kim, Beom Kyung, et al.
Publicado: (2022)

Interaction between the PNPLA3 Gene and Nutritional Factors on NAFLD Development: The Korean Genome and Epidemiology Study
por: Oh, Sooyeon, et al.
Publicado: (2022)

Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
por: Lee, Jung Il, et al.
Publicado: (2019)

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Chon, Young Eun, et al.
Publicado: (2019)

The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study
por: Ha, Yeonjung, et al.
Publicado: (2017)

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
por: Kim, Jong Man, et al.
Publicado: (2022)

Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis
por: Lee, Jae Gon, et al.
Publicado: (2020)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
por: Kim, Mi Na, et al.
Publicado: (2019)

Minimal Hepatic Encephalopathy in Patients with Cirrhosis by Measuring Liver Stiffness and Hepatic Venous Pressure Gradient
por: Sharma, Praveen, et al.
Publicado: (2012)

Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Clinical Utility of Alpha Fetoprotein and HCCR-1, Alone or in Combination, in Patients with Chronic Hepatitis, Liver Cirrhosis and Hepatocellular Carcinoma
por: Jirun, Peng, et al.
Publicado: (2011)

Spleen stiffness-spleen size-to-platelet ratio risk score as noninvasive predictors of esophageal varices in patients with hepatitis B virus-related cirrhosis
por: Cho, Young Seo, et al.
Publicado: (2022)

Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report
por: Cho, Chan Woo, et al.
Publicado: (2018)

Liver stiffness and thrombin generation in compensated cirrhosis
por: Dillon, Audrey, et al.
Publicado: (2019)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
por: Kwon, Soon Ha, et al.
Publicado: (2012)

Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area
por: Shin, Jongbeom, et al.
Publicado: (2021)

A critical role of hepatitis B virus polymerase in cirrhosis, hepatocellular carcinoma, and steatosis
por: Chung, Hea‐Jong, et al.
Publicado: (2017)

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2021)

Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial
por: Kim, Seung Up, et al.
Publicado: (2012)

High Incidence of Hepatitis B Infection-Associated Cirrhosis and Hepatocellular Carcinoma in the Southeast Asian Patients with Portal Vein Thrombosis
por: Lertpipopmetha, Korn, et al.
Publicado: (2011)

Liver stiffness and perfusion changes for hepatic sinusoidal obstruction syndrome in rabbit model
por: Shin, Jaeseung, et al.
Publicado: (2020)

Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study
por: Zhang, Wei, et al.
Publicado: (2019)

A Liver Stiffness Measurement-Based Nomogram Predicts Variceal Rebleeding in Hepatitis B-Related Cirrhosis
por: Liu, Linxiang, et al.
Publicado: (2022)

Pelvic Bone Fractures Mimicking Bone Metastases in a Patient with Hepatitis B Virus-Associated Liver Cirrhosis and Hepatocellular Carcinoma
por: Lee, Dong Hyeon, et al.
Publicado: (2012)

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
por: An, Jihyun, et al.
Publicado: (2022)

Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation
por: Hwang, Jessica P, et al.
Publicado: (2009)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022)

Hepatic hydrothorax without ascites as the first sign of liver cirrhosis
por: Kim, Jung Soo, et al.
Publicado: (2015)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r0gt7sigkaqfmu8t4qj9demebv